Trial intelligence / Profile preview

rh-endostatin with interventional therapy for hepatic metastatic tumor from gastrointestinal tract

ChiCTR-TNRC-10000944Phase 4Completed

Sponsor
Jinling Hospital
Start
Jul 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of endostar in hepatic metastasis and gastrointestinal cancer (2 arms), sponsored by Jinling Hospital. Primary endpoints: MR perfusion, Plain CT and 2 more. Started Jul 2010; status: completed.

02

Drugs

endostar
03

Conditions

hepatic metastasisgastrointestinal cancer

Beyond the preview

Go deeper on ChiCTR-TNRC-10000944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TNRC-10000944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call